Expert Stakeholders’ Views on the Management of Human Pharmaceuticals in the Environment
- 2 September 2006
- journal article
- research article
- Published by Springer Nature in Environmental Management
- Vol. 38 (5) , 853-866
Abstract
Human pharmaceuticals are ubiquitous water contaminants that may have subtle detrimental effects on aquatic organisms, and possibly also on human health. The risks of pharmaceuticals, or pharmaceutically active compounds, remain poorly understood. Awareness of the presence of pharmaceuticals in the environment, coupled with evidence of effects such as fish feminization, however, suggest that precautionary management action to reduce the release of pharmaceuticals to the environment should be considered. The purpose of our study was to evaluate the scope of the issue and possible management strategies from the perspectives of expert stakeholders, drawn from government, academia, and the pharmaceutical and consulting industries, involved in scientific research or policy and management activity, from Canada, the United States, and Europe. Twenty-seven interviewees were asked about their views on management strategies such as pharmaceutical-return programs and incentives for the development of “green” pharmaceuticals. Interviewees generally believed that pharmaceuticals in the environment represented a concern for both human and ecosystem health, although they were more concerned about impacts on aquatic ecosystems. They believed that advanced wastewater treatment technology, education of medical professionals to reduce overprescription, pharmaceutical-return programs coupled with public education, and requirements for all municipalities to have a minimum of secondary wastewater treatment were the most effective management strategies to reduce the environmental impacts of pharmaceuticals. These strategies should be considered by governments interested in managing the risks of human pharmaceuticals in the environment. Combinations of management strategies will likely be most effective in mitigating the risks presented by pharmaceuticals.Keywords
This publication has 53 references indexed in Scilit:
- Impact of Leaky Sewers on Groundwater QualityActa Hydrochimica et Hydrobiologica, 2004
- Hindsight rather than foresight: reality versus the EU draft guideline on pharmaceuticals in the environmentTrends in Biotechnology, 2004
- Gauging the pharmaceutical burden on Sydney’s environment: a preventative responseJournal of Cleaner Production, 2003
- Production of Drinking Water from Highly Contaminated Surface Waters: Removal of Organic, Inorganic, and Microbial Contaminants Applying Mobile Membrane Filtration UnitsPaper presented in parts as a poster at the annual meeting of the Water Chemical Society — a Division of the German Chemical Society (Wasserchemische Gesellschaft — Fachgruppe in der Gesellschaft Deutscher Chemiker), Bad Wildungen, May 2001.Acta Hydrochimica et Hydrobiologica, 2002
- Antidepressants in Aquatic Organisms: A Wide Range of Effects2001
- Widespread Sexual Disruption in Wild FishEnvironmental Science & Technology, 1998
- Occurrence and Distribution of Pharmaceutical Organic Compounds in the Groundwater Downgradient of a Landfill (Grindsted, Denmark)Environmental Science & Technology, 1995
- Estrogenic Effects of Effluents from Sewage Treatment WorksChemistry and Ecology, 1994
- Informing the Public About Uncertain RisksRisk Analysis, 1989
- Toward a Conceptual Framework for Mixed-Method Evaluation DesignsEducational Evaluation and Policy Analysis, 1989